Biohaven (BHVN) Change in Acquisitions & Divestments (2023 - 2026)
Biohaven (BHVN) reported Change in Acquisitions & Divestments of $35.0 million for Q1 2026, down 83.33% on a YoY basis from $210.0 million in Q1 2025, and down 53.33% sequentially from $75.0 million in Q4 2025.
Biohaven (BHVN) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Biohaven (BHVN) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $35.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 83.33% year-over-year to $35.0 million; the trailing twelve-month figure through Mar 2026 stood at $395.0 million (down 1.74% YoY), and the FY2025 full-year result was $570.0 million, up 13.01% from the prior year.
- Change in Acquisitions & Divestments slipped to $35.0 million in Q1 2026, from $75.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $210.0 million in Q1 2025 to a low of $2.5 million in Q2 2023.
- A 4-year average of $99.1 million and a median of $94.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments surged 3149.16% in 2024 and plunged 83.33% in 2026, its largest moves.
- Tracing BHVN's Change in Acquisitions & Divestments over 4 years: stood at $107.9 million in 2023, then surged by 78.02% to $192.0 million in 2024, then slumped by 60.94% to $75.0 million in 2025, then slumped by 53.33% to $35.0 million in 2026.
- Business Quant data shows BHVN's Change in Acquisitions & Divestments at $35.0 million in Q1 2026, $75.0 million in Q4 2025, and $165.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Biohaven | 2.13 Bn | 1.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 165.00 Mn |
| Sep 30, 2025 | 165.00 Mn |
| Jun 30, 2025 | 120.00 Mn |
| Jun 30, 2025 | 120.00 Mn |
| Mar 31, 2025 | 210.00 Mn |
| Mar 31, 2025 | 210.00 Mn |
| Dec 31, 2024 | 192.00 Mn |
| Dec 31, 2024 | 192.00 Mn |
| Mar 31, 2024 | 81.16 Mn |
| Mar 31, 2024 | 81.16 Mn |
| Dec 31, 2023 | 107.86 Mn |
| Dec 31, 2023 | 107.86 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Mar 31, 2023 | 2.50 Mn |